Table 1. Baseline Characteristics of study group overall by qualitative HBeAg status.
| HBeAg positive (n = 27) | HBeAg negative (n = 20) | p-value | |
| Male gender | 17 (63%) | 14 (70%) | 0.615 |
| Median Age at enrolment | 31 | 35 | 0.065 |
| HBV genotype C | 23 (85%) | 16 (80%) | 0.641 |
| Median duration of follow up(weeks) | 120 | 96 | 0.216 |
| Median baseline HBV DNA (log10 IU/mL) | 8.19 | 7.55 | 0.007 |
| Median baseline CD4 (cells/mm3) | 39 | 75 | 0.647 |
| Median baseline HIV RNA (log10 c/mL) | 4.77 | 4.65 | 0.474 |
| Median baseline ALT (IU/L) | 39 | 47 | 0.459 |
| Median baseline qHBsAg (log10 IU/mL) | 5 | 4.12 | 0.002 |
| Median baseline qHBeAg in eAg+ (log10 PE IU/mL) | 3.02 |